Wang, R H

Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients. [electronic resource] - The Journal of clinical investigation Sep 1993 - 1326-35 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0021-9738

10.1172/JCI116706 doi


Anemia, Sickle Cell--blood
Antigens, CD--metabolism
CD55 Antigens
Complement Pathway, Alternative--drug effects
Diamide--pharmacology
Erythrocyte Membrane--chemistry
Humans
Membrane Glycoproteins--metabolism
Membrane Lipids--blood
Oxygen--blood
Phosphatidylethanolamines--blood
Phosphatidylserines--blood
Receptors, Complement 3b--metabolism